NCT00143780View on ClinicalTrials.gov

Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Bone Marrow Transplant
Interventions
BIOLOGICAL

The polysaccharide vaccine used is Pneumovax (Merck vaccines)

BIOLOGICAL

The conjugate vaccine used is Prevnar (Wyeth-Ayerst vaccines)

Trial Locations (1)

M5G 2M9

University Health Network-Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

University Health Network, Toronto

OTHER

NCT00143780 - Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination | Biotech Hunter | Biotech Hunter